Page last updated: 2024-08-26

fibrinogen and Atypical Endometrial Hyperplasia

fibrinogen has been researched along with Atypical Endometrial Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies

Trials

1 trial(s) available for fibrinogen and Atypical Endometrial Hyperplasia

Article	Year
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA, 1995, Jan-18, Volume: 273, Issue:3 Topics: Aged; Cholesterol, HDL; Double-Blind Method; Drug Administration Schedule; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Glucose; Heart Diseases; Humans; Insulin; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Systole; Weight Gain	1995

Article

Year

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

JAMA, 1995, Jan-18, Volume: 273, Issue:3

Topics: Aged; Cholesterol, HDL; Double-Blind Method; Drug Administration Schedule; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Glucose; Heart Diseases; Humans; Insulin; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Systole; Weight Gain

1995